We are live on
!
Find out more
B
Bailard Portfolio holdings
AUM
$4.35B
1-Year Est. Return
23.57%
This Fund
S&P 500
This Quarter
Est. Return
+4.29%
1 Year Est. Return
+23.57%
3 Year Est. Return
+74.84%
5 Year Est. Return
+96.64%
10 Year Est. Return
+374.16%
AUM
$1.64B
AUM Growth
+$23.5M
(+1.5%)
Cap. Flow
-$31.1M
Cap. Flow
% of AUM
-1.9%
Top 10 Holdings %
Top 10 Hldgs %
31.5%
Holding
630
New
91
Increased
163
Reduced
168
Closed
91
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$56.7M |
| 2 |
Vanguard Total Bond Market
BND
|
+$56M |
| 3 |
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
|
+$16.8M |
| 4 |
iShares US Treasury Bond ETF
GOVT
|
+$11.4M |
| 5 |
iShares MBS ETF
MBB
|
+$11.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$58.5M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$31.9M |
| 3 |
iShares Gold Trust
IAU
|
+$29.4M |
| 4 |
SPDR Gold Trust
GLD
|
+$22.9M |
| 5 |
State Street SPDR Nuveen ICE Municipal Bond ETF
TFI
|
+$8.19M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.03% |
| 2 | Healthcare | 7.09% |
| 3 | Financials | 4.96% |
| 4 | Communication Services | 4.91% |
| 5 | Industrials | 4.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
STR
526
DELISTED
Sitio Royalties
STR
| $119K | 0.01% |
+3,550
| New | +$117K |
|
|
JNCE
527
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $113K | 0.01% |
22,800
+8,000
| +54% | +$42.5K |
|
528
GE Aerospace
GE
$354B
| $108K | 0.01% |
2,065
-18,708
| -90% | -$921K |
|
529
Accuray
ARAY
$28.7M
| $106K | 0.01% |
27,400
+6,100
| +29% | +$24.6K |
|
530
CareCloud
CCLD
$93.1M
| $106K | 0.01% |
20,897
-21,200
| -50% | -$105K |
|
531
Cumberland Pharmaceuticals
CPIX
$107M
| $92K | 0.01% |
+14,516
| New | +$88K |
|
532
Orion Energy Systems
OESX
$41.8M
| $91K | 0.01% |
+3,050
| New | +$60.6K |
|
|
FPRX
533
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $78K | ﹤0.01% |
13,000
+2,500
| +24% | +$23.9K |
|
534
Akebia Therapeutics
AKBA
$338M
| $72K | ﹤0.01% |
14,900
| – | – |
|
535
Extreme Networks
EXTR
$3.96B
| $68K | ﹤0.01% |
+10,550
| New | +$69.7K |
|
536
Ardelyx
ARDX
$1.25B
| $62K | ﹤0.01% |
23,141
| – | – |
|
537
Cineverse
CNVS
$57.8M
| $62K | ﹤0.01% |
2,305
| – | – |
|
538
Banco Bilbao Vizcaya Argentaria
BBVA
$145B
| $59K | ﹤0.01% |
+10,649
| New | +$61.9K |
|
539
Coffee Holding Co
JVA
$20.1M
| $47K | ﹤0.01% |
11,503
-6,000
| -34% | -$28.9K |
|
540
Arbutus Biopharma
ABUS
$855M
| – | – |
-228,000
| Closed | -$816K |
|
541
Acco Brands
ACCO
$375M
| – | – |
-56,300
| Closed | -$482K |
|
542
Alpha Metallurgical Resources
AMR
$1.86B
| – | – |
-7,400
| Closed | -$429K |
|
543
Digital Turbine
APPS
$1.03B
| – | – |
-66,700
| Closed | -$233K |
|
544
Banner Corp
BANR
$2.37B
| – | – |
-9,330
| Closed | -$505K |
|
545
Brunswick
BC
$5.33B
| – | – |
-8,200
| Closed | -$413K |
|
|
BELFB
546
Bel Fuse Inc Class B
BELFB
$4.01B
| – | – |
-8,294
| Closed | -$210K |
|
|
BFIN
547
DELISTED
BankFinancial
BFIN
| – | – |
-22,603
| Closed | -$336K |
|
548
Boston Properties
BXP
$10.8B
| – | – |
-2,585
| Closed | -$346K |
|
549
Citigroup
C
$222B
| – | – |
-5,868
| Closed | -$365K |
|
550
Clarus
CLAR
$129M
| – | – |
-12,957
| Closed | -$165K |
|
Similar funds
EC
SFM
NHC
EQF
CCM
NEI
Bailard's Q2 2019 Portfolio in Review
As of Q2 2019, Bailard held 630 positions worth $1.64B, up 1.5% from $1.61B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Bailard's Q2 2019 filing shows 91 new, 163 increased, 168 reduced and 91 closed positions. Its largest new stake was Vanguard Total Bond Market: 687,016 shares worth $57.1M. The largest sale was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund, an estimated $58.5M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Financials.
- Bailard's largest Q2 2019 buy was Vanguard Total Bond Market: 687,016 shares worth $57.1M.
- Bailard added most to iShares US Real Estate ETF in Q2 2019, an estimated $56.7M increase.
- Bailard's biggest Q2 2019 reduction was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund, cutting an estimated $58.5M.
- Bailard fully exited Teva Pharmaceuticals in Q2 2019, selling an estimated $5.65M.
- Bailard's ten largest holdings make up 32% of its $1.64B portfolio in Q2 2019.
- Bailard opened 91 new positions and closed 91 in Q2 2019.
- Bailard's portfolio value rose 1.5% quarter-over-quarter to $1.64B.
Based on Bailard's 13F filing for Q2 2019, filed 26 Jul 2019.